Transcription factor Oct4 promotes osteosarcoma by regulating lncRNA AK055347
Open Access
- 21 November 2016
- journal article
- Published by Spandidos Publications in Oncology Letters
- Vol. 13 (1) , 396-402
Abstract
Osteosarcoma is the most common primary bone tumor in children and adolescents, typically presenting with a poor prognosis. Octamer-binding transcription factor 4 (Oct4) protein, encoded by the POU class 5 homeobox 1 gene, is important in maintaining self-renewal of pluripotent stem cells, and is closely associated with cancer. However, its role in osteosarcoma remains to be elucidated. The present study observed Oct4 was markedly increased in osteosarcoma cell lines and in human osteosarcoma tissue samples. Following Oct4 downregulation by small interfering RNA (siRNA) in osteosarcoma F5M2 cells, the cells exhibited significant decreases in proliferation and invasion ability, and an increase in cell apoptosis. Notably, downregulation of Oct4 decreased the expression of AK055347, a newly identified long noncoding RNA (lncRNA) in human tissues. The downregulation of AK055347 by siRNA resulted in a significant suppressive effect on proliferative and invasive ability, and promotion of cell apoptosis in osteosarcoma cells. Thus, the current study suggests Oct4 exerts a promoting effect in osteosarcoma, and identifies a novel lncRNA in osteosarcoma progression.Keywords
This publication has 31 references indexed in Scilit:
- Activation of IL6/IGFIR Confers Poor Prognosis of HBV-Related Hepatocellular Carcinoma through Induction of OCT4/NANOG ExpressionClinical Cancer Research, 2015
- Transcription factor OCT4 promotes cell cycle progression by regulating CCND1 expression in esophageal carcinomaCancer Letters, 2014
- Differential expression of stem cell markers and ABCG2 in recurrent prostate cancerThe Prostate, 2014
- Transcriptional activation of OCT4 by the ETS transcription factor PEA3 in NCCIT human embryonic carcinoma cellsFEBS Letters, 2014
- Functional Characteristics of Reversibly Immortalized Hepatic Progenitor Cells Derived from Mouse Embryonic LiverCellular Physiology and Biochemistry, 2014
- Nanog and Oct4 overexpression increases motility and transmigration of melanoma cellsJournal of Cancer Research and Clinical Oncology, 2012
- Salinomycin inhibits osteosarcoma by targeting its tumor stem cellsCancer Letters, 2011
- Oct4 is expressed in human gliomas and promotes colony formation in glioma cellsGlia, 2008
- Oct-3/4 Expression Reflects Tumor Progression and Regulates Motility of Bladder Cancer CellsCancer Research, 2008
- Core Transcriptional Regulatory Circuitry in Human Embryonic Stem CellsCell, 2005